Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spero Therapeutics (SPRO) Prepaid Assets (2016 - 2025)

Spero Therapeutics' Prepaid Assets history spans 10 years, with the latest figure at $1.6 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 14.5% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 14.5%, while the annual FY2025 figure was $1.6 million, 14.5% down from the prior year.
  • Prepaid Assets reached $1.6 million in Q4 2025 per SPRO's latest filing, up from $1.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.8 million in Q4 2021 to a low of $1.2 million in Q3 2025.
  • Average Prepaid Assets over 5 years is $4.1 million, with a median of $3.6 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: tumbled 74.2% in 2022, then skyrocketed 263.44% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $8.8 million in 2021, then crashed by 61.73% to $3.4 million in 2022, then rose by 23.65% to $4.2 million in 2023, then tumbled by 54.26% to $1.9 million in 2024, then decreased by 14.5% to $1.6 million in 2025.
  • Per Business Quant, the three most recent readings for SPRO's Prepaid Assets are $1.6 million (Q4 2025), $1.2 million (Q3 2025), and $1.3 million (Q2 2025).